Key Notes
- UnitedHealth reported adjusted Q3 earnings of $4.69 per share, exceeding the $4.14 analyst estimate.
- The company lifted its 2026 adjusted earnings outlook to at least $20.50 per share.
- Its medical-care ratio improved to 88.4%, including a $610 million favorable adjustment to earlier claims reserves.
UnitedHealth Group Inc. (NYSE: UNH) raised its 2026 adjusted profit outlook to at least $20.50 per share after third-quarter earnings exceeded Wall Street estimates, extending its recovery as it works to contain elevated medical costs.
The healthcare company reported adjusted earnings of $4.69 per share and revenue of $112.69 billion for the quarter ended September 30. The results put profitability ahead of expectations even as revenue edged below the same period a year earlier.
The higher guidance follows the $19.50–$20.00 adjusted earnings range UnitedHealth set with its July results. The latest outlook incorporates experience through the third quarter and sets a higher minimum for the full year.
Earnings Beat Expectations as Revenue Edges Lower
CNBC reported the following comparisons with analyst estimates, drawing on LSEG and StreetAccount data:
- Adjusted earnings per share: $4.69, compared with $4.14 expected.
- Revenue: $112.69 billion, compared with $111.40 billion expected.
- Medical-care ratio: 88.4%, compared with 89.9% expected.
Net income attributable to common shareholders rose to $4.11 billion, or $4.56 per share, from $2.35 billion, or $2.59 per share, a year earlier. Adjusted earnings increased from $2.92 per share in the prior-year quarter.
The distinction between reported and adjusted profit matters. UnitedHealth’s reconciliation accounts for intangible amortization, portfolio divestitures and South American impacts, and restructuring and other items. The adjusted figure complements the accounting result rather than replacing it.
Revenue slipped from $113.16 billion in the third quarter of 2025. The recovery in earnings therefore reflects improved profitability rather than a broad acceleration in sales.
Medical Costs Improve but Remain Elevated
UnitedHealth’s 88.4% medical-care ratio was lower than the 89.9% recorded a year earlier. The measure compares medical expenses with premium revenue, making it an important indicator of how much room the insurance business has to cover administration and earn a profit.
The company attributed the improvement to medical-cost management, pricing discipline, benefit changes and care-delivery initiatives. It also disclosed $610 million of favorable reserve development related to healthcare services provided earlier in 2026.
That adjustment is relevant to earnings quality: revisions to earlier claims estimates affect the quarter’s reported costs. Investors assessing the recovery will need to distinguish those revisions from improvements that can be repeated through pricing and day-to-day operations.
Chief Financial Officer Wayne DeVeydt told CNBC that medical costs remained elevated relative to historical norms despite the better ratio. He identified inpatient services, specialty pharmacy and out-of-network payment disputes as continuing sources of pressure.
UnitedHealthcare Trades Some Membership for Better Margins
UnitedHealthcare, the insurance division, generated $86.3 billion of quarterly revenue and $2.8 billion of operating earnings. Its operating margin improved to 3.3% from 2.1% a year earlier, while the business served 48.3 million people.
Enrollment changes help explain the revenue picture. Medicare Advantage membership, including programs serving complex populations within Medicaid, had contracted by 935,000 since the end of 2025. Employer and individual membership fell by 165,000 during the quarter, while Community & State enrollment declined by 85,000.
The figures show the trade-off in the company’s recovery effort. Serving fewer members can reduce revenue while changes in product mix, pricing and medical costs improve the profitability of the remaining business.
Optum’s Recovery Varies Across Its Businesses
Optum generated $66.9 billion in revenue and $3.7 billion of operating earnings. The healthcare-services division includes care delivery, analytics and technology, and pharmacy services, giving UnitedHealth several sources of earnings beyond insurance premiums.
Optum Health revenue fell 10% to $22.9 billion as it served fewer value-based care patients in markets where its presence was insufficient to sustain its clinicians. Operating earnings nevertheless improved to $735 million from $41 million a year earlier.
Optum Insight reported $5.5 billion of revenue and $1.3 billion of operating earnings, while Optum Rx generated $39.9 billion of revenue and $1.7 billion of operating earnings. Pharmacy adjusted prescriptions declined to 393 million from 414 million, reflecting membership reductions at UnitedHealthcare and other customers.
DeVeydt told CNBC that hospital admissions among members had fallen 15% year over year through the third quarter, while home-health admissions rose 10%. He said value-based care and technology investments were helping direct patients toward appropriate, lower-cost settings.
Cash Generation and the Higher Outlook Set the Next Test
Operating cash flow reached $5.1 billion for the quarter. UnitedHealth’s debt-to-capital ratio was 41.7% at September 30, compared with 41.2% in June; it continues to target approximately 40% by year-end.
The company had repurchased $5 billion of shares and paid $6.2 billion in dividends during the first nine months. Its updated full-year outlook calls for reported earnings of at least $19.50 per share alongside adjusted earnings of at least $20.50.
The next test is whether the margin recovery holds as medical costs remain high and enrollment changes continue to affect revenue. The third-quarter beat and higher guidance strengthen the financial picture, while reserve development and the different trends across Optum make the composition of that improvement important.
